http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107468665-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 |
filingDate | 2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107468665-B |
titleOfInvention | A kind of olaparib composition capsule |
abstract | The present invention relates to field of medicine preparations, specifically disclose a kind of olaparib composition capsule.Olaparib composition capsule of the present invention includes olaparib, starch, toluene di-tert-butyl phenol, sodium alginate, Compritol 888 ATO.The preferred olaparib of the present invention, the composition of starch, toluene di-tert-butyl phenol, sodium alginate, Compritol 888 ATO as olaparib capsule, mutually stability, mobility and the dissolution rate of synergistic effect raising olaparib, moisture content is reduced, the safe handling and long term storage of clinical medicine are conducive to. |
priorityDate | 2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.